Charles River Laboratories (CRL) Revenue & Revenue Breakdown
Charles River Laboratories Revenue Highlights
Latest Revenue (Y)
$4.13B
Latest Revenue (Q)
$1.03B
Main Segment (Y)
Service
Main Geography (Y)
UNITED STATES
Charles River Laboratories Revenue by Period
Charles River Laboratories Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-30 | $4.13B | 3.86% |
| 2022-12-31 | $3.98B | 12.31% |
| 2021-12-25 | $3.54B | 21.08% |
| 2020-12-26 | $2.92B | 11.55% |
| 2019-12-28 | $2.62B | 15.67% |
| 2018-12-29 | $2.27B | 21.99% |
| 2017-12-30 | $1.86B | 10.48% |
| 2016-12-31 | $1.68B | 23.34% |
| 2015-12-26 | $1.36B | 5.06% |
| 2014-12-27 | $1.30B | 11.34% |
| 2013-12-28 | $1.17B | 3.19% |
| 2012-12-29 | $1.13B | -1.15% |
| 2011-12-31 | $1.14B | 0.81% |
| 2010-12-25 | $1.13B | -5.75% |
| 2009-12-26 | $1.20B | -10.49% |
| 2008-12-27 | $1.34B | 9.17% |
| 2007-12-29 | $1.23B | 16.27% |
| 2006-12-30 | $1.06B | -5.69% |
| 2005-12-31 | $1.12B | 46.33% |
| 2004-12-25 | $766.92M | 24.96% |
| 2003-12-27 | $613.72M | 10.65% |
| 2002-12-28 | $554.63M | 19.11% |
| 2001-12-29 | $465.63M | 51.88% |
| 2000-12-31 | $306.58M | 39.82% |
| 1999-12-25 | $219.28M | 13.44% |
| 1998-12-31 | $193.30M | - |
Charles River Laboratories generated $4.13B in revenue during NA 2023, up 3.86% compared to the previous quarter, and up 182.23% compared to the same period a year ago.
Charles River Laboratories Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-29 | $1.03B | 1.44% |
| 2024-03-30 | $1.01B | -0.19% |
| 2023-12-30 | $1.01B | -1.28% |
| 2023-09-30 | $1.03B | -3.14% |
| 2023-07-01 | $1.06B | 2.97% |
| 2023-04-01 | $1.03B | -6.41% |
| 2022-12-31 | $1.10B | 11.19% |
| 2022-09-24 | $989.16M | 1.65% |
| 2022-06-25 | $973.13M | 6.48% |
| 2022-03-26 | $913.93M | 0.98% |
| 2021-12-25 | $905.05M | 1.02% |
| 2021-09-25 | $895.94M | -2.04% |
| 2021-06-26 | $914.61M | 10.92% |
| 2021-03-27 | $824.57M | 4.24% |
| 2020-12-26 | $790.99M | 6.42% |
| 2020-09-26 | $743.30M | 8.90% |
| 2020-06-27 | $682.58M | -3.46% |
| 2020-03-28 | $707.06M | 2.30% |
| 2019-12-28 | $691.14M | 3.47% |
| 2019-09-28 | $667.95M | 1.58% |
| 2019-06-29 | $657.57M | 8.77% |
| 2019-03-30 | $604.57M | 0.51% |
| 2018-12-29 | $601.53M | 2.77% |
| 2018-09-29 | $585.29M | -0.00% |
| 2018-06-30 | $585.30M | 18.49% |
| 2018-03-31 | $493.97M | 3.24% |
| 2017-12-30 | $478.48M | 3.07% |
| 2017-09-30 | $464.23M | -1.04% |
| 2017-07-01 | $469.13M | 5.24% |
| 2017-04-01 | $445.76M | -4.50% |
| 2016-12-31 | $466.79M | 9.65% |
| 2016-09-24 | $425.72M | -1.92% |
| 2016-06-25 | $434.06M | 22.31% |
| 2016-03-26 | $354.87M | 0.29% |
| 2015-12-26 | $353.85M | 1.25% |
| 2015-09-26 | $349.46M | 2.91% |
| 2015-06-27 | $339.57M | 5.98% |
| 2015-03-28 | $320.41M | -2.77% |
| 2014-12-27 | $329.55M | 0.60% |
| 2014-09-27 | $327.57M | -3.99% |
| 2014-06-28 | $341.18M | 13.97% |
| 2014-03-29 | $299.37M | 3.51% |
| 2013-12-28 | $289.23M | -0.99% |
| 2013-09-28 | $292.13M | -0.27% |
| 2013-06-29 | $292.93M | 0.58% |
| 2013-03-30 | $291.24M | 3.96% |
| 2012-12-29 | $280.14M | 0.52% |
| 2012-09-29 | $278.69M | -2.12% |
| 2012-06-30 | $284.72M | -0.44% |
| 2012-03-31 | $285.98M | -1.71% |
| 2011-12-31 | $290.96M | 4.82% |
| 2011-09-24 | $277.58M | -3.71% |
| 2011-06-25 | $288.26M | 0.85% |
| 2011-03-26 | $285.84M | 6.70% |
| 2010-12-25 | $267.89M | -2.97% |
| 2010-09-25 | $276.08M | -5.49% |
| 2010-06-26 | $292.10M | -1.76% |
| 2010-03-27 | $297.35M | 0.66% |
| 2009-12-26 | $295.38M | -0.71% |
| 2009-09-26 | $297.49M | -3.46% |
| 2009-06-27 | $308.16M | 2.20% |
| 2009-03-28 | $301.53M | -3.19% |
| 2008-12-27 | $311.45M | -8.99% |
| 2008-09-27 | $342.23M | -2.81% |
| 2008-06-28 | $352.13M | 4.28% |
| 2008-03-29 | $337.69M | 6.18% |
| 2007-12-29 | $318.03M | - |
Charles River Laboratories generated $1.03B in revenue during Q2 2024, up 1.44% compared to the previous quarter, and up 99.68% compared to the same period a year ago.
Charles River Laboratories Revenue Breakdown
Charles River Laboratories Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Product | $689.39M | $759.16M | $784.58M | $627.78M | $591.86M |
| Service | $3.44B | $3.22B | $2.76B | $2.30B | $2.03B |
Charles River Laboratories's latest annual revenue breakdown by segment (product or service), as of Dec 23: Service (83.31%), and Product (16.69%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Jul 23 | Apr 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Manufacturing Support | $185.20M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Service | $816.86M | $838.00M | $869.76M | $874.89M | $857.37M | $900.70M | $812.89M | $782.83M | $720.49M | $709.82M | $703.86M | $715.32M | $626.58M | $618.23M | $580.77M | $550.56M | $546.59M | $549.38M | $523.17M | $505.88M |
| Discovery and Safety Assessment | $605.45M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Product | $194.70M | $175.47M | $156.86M | $185.05M | $172.01M | $199.15M | $176.26M | $190.30M | $193.44M | $195.23M | $192.08M | $199.29M | $197.99M | $172.76M | $162.53M | $132.02M | $160.47M | $141.76M | $144.78M | $151.69M |
Charles River Laboratories's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Service (45.33%), Discovery and Safety Assessment (33.59%), Product (10.80%), and Manufacturing Support (10.28%).
Charles River Laboratories Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Europe | $1.08B | $1.03B | $1.04B | $829.31M | $726.42M |
| Other | $16.85M | $9.96M | $7.29M | $6.13M | $5.50M |
| Asia Pacific | $200.83M | $192.84M | $222.90M | - | - |
| CANADA | $487.31M | $398.98M | $339.10M | $306.26M | $271.99M |
| UNITED STATES | $2.35B | $2.34B | $1.93B | $1.63B | $1.47B |
| JAPAN | - | - | - | $155.09M | $146.22M |
Charles River Laboratories's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (56.85%), Europe (26.08%), CANADA (11.80%), Asia Pacific (4.86%), and Other (0.41%).
Quarterly Revenue by Country
| Country | Mar 24 | Dec 23 | Sep 23 | Jul 23 | Apr 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Europe | $276.32M | $271.47M | $264.79M | $272.98M | $267.70M | $271.53M | $245.93M | $263.58M | $251.09M | $264.87M | $258.35M | $275.71M | $237.53M | $233.92M | $214.19M | $190.94M | $190.26M | $192.60M | $184.69M | $182.77M |
| Asia Pacific | $45.77M | $57.92M | $40.23M | $59.86M | $42.81M | $53.85M | $43.80M | $46.24M | $48.95M | $51.72M | $56.61M | $55.13M | $59.45M | $41.55M | $35.97M | $31.83M | $36.70M | $36.21M | - | - |
| CANADA | $110.40M | $130.03M | $129.02M | $117.65M | $110.61M | $118.44M | $101.60M | $93.69M | $85.25M | $86.17M | $85.25M | $90.56M | $77.11M | $79.09M | $79.00M | $71.54M | $76.63M | $77.12M | $71.98M | $68.90M |
| UNITED STATES | $562.32M | $544.95M | $590.32M | $606.77M | $605.44M | $653.43M | $595.26M | $566.92M | $526.55M | $500.74M | $493.56M | $491.62M | $448.48M | $430.54M | $406.98M | $382.92M | $406.71M | $379.90M | $373.09M | $367.92M |
| Other | $16.75M | $9.10M | $2.26M | $2.67M | $2.81M | $2.60M | $2.56M | $2.70M | $2.10M | $1.55M | $2.16M | $1.58M | $2.00M | $1.70M | $1.58M | $1.22M | $1.62M | $1.38M | $1.49M | $1.76M |
Charles River Laboratories's latest quarterly revenue breakdown by geography, as of Mar 24: UNITED STATES (55.59%), Europe (27.32%), CANADA (10.91%), Asia Pacific (4.52%), and Other (1.66%).
Charles River Laboratories Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| IQV | IQVIA | $14.98B | $3.81B |
| LH | Laboratory Corporation of America | $12.16B | $3.22B |
| ICLR | ICON Public Limited Company | $8.12B | $2.09B |
| A | Agilent | $6.83B | $1.58B |
| ILMN | Illumina | $4.50B | $1.08B |
| CRL | Charles River Laboratories | $4.13B | $1.03B |
| MTD | Mettler-Toledo | $3.79B | $946.75M |
| IDXX | IDEXX Laboratories | $3.66B | $1.00B |
| WAT | Waters | $2.96B | $708.53M |
| RVTY | Revvity | $2.75B | $691.68M |
| MEDP | Medpace | $1.89B | $528.10M |
| GH | Guardant Health | $563.95M | $177.24M |
| CDNA | CareDx | $280.32M | $92.27M |
CRL Revenue FAQ
What is Charles River Laboratories’s yearly revenue?
Charles River Laboratories's yearly revenue for 2023 was $4.13B, representing an increase of 3.86% compared to 2022. The company's yearly revenue for 2022 was $3.98B, representing an increase of 12.31% compared to 2021. CRL's yearly revenue for 2021 was $3.54B, representing an increase of 21.08% compared to 2020.
What is Charles River Laboratories’s quarterly revenue?
Charles River Laboratories's quarterly revenue for Q2 2024 was $1.03B, a 1.44% increase from the previous quarter (Q1 2024), and a -3.19% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $1.01B, a -0.19% decrease from the previous quarter (Q4 2023), and a -1.73% decrease year-over-year (Q1 2023). CRL's quarterly revenue for Q4 2023 was $1.01B, a -1.28% decrease from the previous quarter (Q3 2023), and a -7.85% decrease year-over-year (Q4 2022).
What is Charles River Laboratories’s revenue growth rate?
Charles River Laboratories's revenue growth rate for the last 3 years (2021-2023) was 16.64%, and for the last 5 years (2019-2023) was 57.54%.
What are Charles River Laboratories’s revenue streams?
Charles River Laboratories's revenue streams in c 23 are Product, and Service. Product generated $689.39M in revenue, accounting 16.69% of the company's total revenue, down -9.19% year-over-year. Service generated $3.44B in revenue, accounting 83.31% of the company's total revenue, up 6.94% year-over-year.
What is Charles River Laboratories’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Charles River Laboratories was Service. This segment made a revenue of $3.44B, representing 83.31% of the company's total revenue.